|
ZCCHC17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.015500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.380600E-03 |
| Normal-vs-Stage2 |
2.040300E-02 |
| Normal-vs-Stage3 |
1.733790E-02 |
| Normal-vs-Stage4 |
2.943200E-01 |
| Stage1-vs-Stage2 |
6.529200E-01 |
| Stage1-vs-Stage3 |
7.871800E-01 |
| Stage1-vs-Stage4 |
7.859200E-01 |
| Stage2-vs-Stage3 |
8.723000E-01 |
| Stage2-vs-Stage4 |
6.680600E-01 |
| Stage3-vs-Stage4 |
7.253600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.045800E-04 |
| Normal-vs-AfricanAmerican |
1.883680E-02 |
| Normal-vs-Asian |
1.289150E-01 |
| Caucasian-vs-AfricanAmerican |
4.765200E-01 |
| Caucasian-vs-Asian |
9.640200E-01 |
| AfricanAmerican-vs-Asian |
8.224000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.408000E-04 |
| Normal-vs-Female |
1.481240E-01 |
| Male-vs-Female |
5.579300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.100010E-02 |
| Normal-vs-Extreme_Weight |
1.924420E-03 |
| Normal-vs-Obese |
6.981100E-03 |
| Normal-vs-Extreme_Obese |
3.213700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.536800E-01 |
| Normal_Weight-vs-Obese |
9.406200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.296200E-01 |
| Extreme_Weight-vs-Obese |
7.543600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.945800E-01 |
| Obese-vs-Extreme_Obese |
8.792400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.613400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.671600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.384720E-03 |
| Normal-vs-Age(81-100Yrs) |
3.142600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.718000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.976390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.241200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.304560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.809550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.886400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.716410E-02 |
| Normal-VS-Type2 PRCC |
1.52549999998808E-06 |
| Normal-VS-KIRP CIMP |
3.391400E-01 |
| Normal-VS-Unclassified PRCC |
1.089940E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.759400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.916100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.037400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.97600000000953E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.064400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.179300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.423100E-04 |
| Normal-vs-N1 |
2.460800E-01 |
| Normal-vs-N2 |
9.775800E-01 |
| N0-vs-N1 |
3.920200E-01 |
| N0-vs-N2 |
5.791400E-01 |
| N1-vs-N2 |
6.709000E-01 |
|
|
